Press release
Navigating the Future: Neuropathic Pain Market Trends and Forecast Insights, 2025 Edition
Neuropathic Pain Market Size
Neuropathic Pain Market Size Growth Forecast: What to Expect by 2025?
The market size for neuropathic pain has seen substantial growth recently. It is anticipated to increase from $5.35 billion in 2024 to $5.79 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.2%. The past growth can be credited to several factors, including high demand for neuropathic pain medication, an epidemic of chronic pain, rising demand for prescribed treatments, and government initiatives.
How Will the Neuropathic Pain Market Size Evolve and Grow by 2029?
The market size for neuropathic pain is predicted to witness significant expansion in the coming years, estimated to reach $7.76 billion in 2029, with a compound annual growth rate (CAGR) of 7.6%. The surge during this forecast duration is ascribed to an increasing understanding of neuropathic pain, the growing elderly population, a well-established healthcare sector, and the availability of treatments for neuropathic pain. The foreseeable future is set to witness trends such as enhanced diagnostics, progress in pain management techniques, advancements in medical research, approvals for new drugs, and strategic initiatives.
View the full report here:
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report
What Drivers Are Propelling the Growth of Neuropathic Pain Market Forward?
The neuropathic pain market's expansion is anticipated to be fueled by an increase in chronic pain prevalence. Chronic pain denotes a pain that persists for a time longer than the predicted healing period of a disease or injury. It often lasts for a minimum of three to six months. The growing incidences of chronic pain, inclusive of neuropathic illnesses, necessitate effective treatments, thereby encouraging research, innovation, and the investment in the development of better therapies to improve symptom relief and quality of life. For example, the Scottish Health Survey 2022, conducted by the Scotland-based Scottish Government, indicated that over a third (38%) of Scottish adults reported the experience of pain or discomfort lasting over three months in 2022, with a higher frequency in females (43%) as opposed to males (33%). Consequently, the increasing cases of chronic pain are propelling the neuropathic pain market's growth. Neuropathic Pain Market Driver: The Expected Increase in Diabetes Cases Fuels Neuropathic Pain Market Expansion
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12922&type=smp
Which Emerging Trends Are Transforming the Neuropathic Pain Market in 2025?
Leading corporations in the neuropathic pain market are turning to artificial intelligence (AI) technology to progress diagnosis procedures, personalize treatment schemes, supervise in real-time, discover new drugs, and extract data-driven knowledge to augment patient results and fine-tune pain control tactics. For example, Nevro Corp., a medical device firm from the US, rolled out the new Senza HFX iQ spinal cord stimulation (SCS) system in March 2023. This forward-thinking system uses AI to individualize pain management for each patient. The SCS system, comprising of the HFX iQ Implantable Pulse Generator (IPG), HFX Trial Stimulator, Charger, and HFX App, aims to treat non-surgical back discomfort and painful diabetic neuropathy by adjusting to each patient's feedback and responses. By utilizing a distinctive algorithm grounded on extensive patient data, the system allows the patient to modify their pain control program with a smartphone application. The system's digital platform supports data gathering and future updates. This technology's goal is to improve consistent and personalized pain relief, representing a notable progression in SCS therapy.
What Are the Key Segments in the Neuropathic Pain Market?
The neuropathic pain market covered in this report is segmented -
1) By Treatment: Medications, Multimodal Therapy
2) By Diagnosis: Imaging, Blood Tests And Physical Examination
3) By Indication: Diabetic Neuropathy, Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Other Indications
4) By End User: Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Medications: Anticonvulsants, Antidepressants, Opioids, Topical Treatments, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2) By Multimodal Therapy: Combination Of Medications, Physical Therapy, Psychological Therapy, Lifestyle Modifications, Complementary Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12922&type=smp
Who Are the Key Players Shaping the Neuropathic Pain Market's Competitive Landscape?
Major companies operating in the neuropathic pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Medtronic Inc., Eli Lilly and Company, Stryker Corporation, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Biogen Inc., Zimmer Biomet Holdings Inc., Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Lupin Ltd., NuVasive Inc., Integer Holdings Corporation, Avanos Medical Inc., Orthofix Medical Inc., Nevro Corp., InvaGen Pharmaceuticals Inc., B. Braun Melsungen AG, Cirtec Medical Corp., Centaur Pharmaceuticals Pvt Ltd., Stimwave LLC, DePuy Synthes.
What Geographic Markets Are Powering Growth in the Neuropathic Pain Market?
North America was the largest region in the neuropathic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuropathic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12922
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Navigating the Future: Neuropathic Pain Market Trends and Forecast Insights, 2025 Edition here
News-ID: 4125749 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Neuropathic
Key Trends Reshaping the Neuropathic Pain Market: Integration Of Artificial Inte …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neuropathic Pain Market Size Growth Forecast: What to Expect by 2025?
The market valuation for neuropathic pain has experienced robust expansion lately, projected to ascend from a figure of $5.35 billion in 2024 to $5.78 billion the following year, reflecting a steady compound annual growth rate (CAGR) of 7.9%;…
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
